← All companies
OSTX
OS Therapies Incorporated
$1.55
-0.01 -0.64%
Key statistics
from XBRL data in SEC filingsMarket cap
$69.0M
Revenue (TTM)
—
Net income (TTM)
-$35.3M
EPS (TTM)
$-1.07
P/E ratio
—
Dividend yield
—
Free cash flow
-$14.7M
Cash
$918K
Total assets
$7.30M
Gross margin
—
52-week range
$1.15 – $2.57
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Terminated a material agreement
Jul 29, 2026
8-K/A
AMENDMENT NO. 1 TO FORM 8-K
Jul 7, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Other events
Jul 2, 2026
10-Q
Quarter ended 2026-03-31
May 18, 2026
8-K
Regulation FD disclosure
Apr 30, 2026
8-K
Entered a material agreement; Other events
Apr 2, 2026
8-K
Other events
Mar 31, 2026
10-K
Fiscal year ended 2025-12-31
Mar 31, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Mar 6, 2026
8-K
Other events
Feb 13, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jan 12, 2026
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Director or officer change; Shareholder vote results
Oct 21, 2025
8-K
Regulation FD disclosure; Other events
Oct 17, 2025
8-K
Other events
Sep 30, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Sep 2, 2025
8-K
Terminated a material agreement; Other events
Aug 26, 2025
8-K
Results of operations (earnings release)
Aug 19, 2025
10-Q
Quarter ended 2025-06-30
Aug 18, 2025
8-K
Amended charter or bylaws
Aug 15, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jul 14, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Jun 27, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jun 24, 2025
8-K
Results of operations (earnings release)
May 16, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Completed an acquisition or disposition; Unregistered sale of equity; Other events
Apr 15, 2025
8-K
Shareholder vote results
Apr 9, 2025
8-K
Other events
Apr 2, 2025
8-K
Results of operations (earnings release)
Mar 31, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events
Jan 29, 2025
8-K
Other events
Jan 15, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Jan 14, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jan 3, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events
Dec 30, 2024
8-K
Results of operations (earnings release)
Nov 15, 2024
10-Q
Quarter ended 2024-09-30
Nov 15, 2024
8-K
Entered a material agreement; Unregistered sale of equity
Nov 1, 2024
8-K
Director or officer change
Oct 28, 2024
8-K
Other events
Aug 22, 2024